2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-07
±³À°ÀÏÀÚ : 2023-11-07
±³À°Àå¼Ò : ´ëÀüÄÁº¥¼Ç¼¾ÅÍ Á¦1Àü½ÃÀå 2Ãþ ±×·£µåº¼·ë, 204-205È£
±³À°ÁÖÁ¦ : 2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѾฮÇÐȸ
´ã´çÀÚ : ½Å¼öÀÎ
¿¬¶ôó : 02-326-0370
À̸ÞÀÏ : head@kosphar.org
±³À°Á¾·ù : »ý¸®ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 11 ½Ã°£ 28ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í ÆòÀÇ¿ø & Á¤È¸¿ø 15¸¸¿ø, ÁØȸ¿ø (Çлýȸ¿ø) 8¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:00~09:20 Comprehensive genomic characterization of Korean advanced pan-cancer patients facilitates personalized »ç°æÇÏ(°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:20~09:40 Building human single-cell atlas for disease modelling and cell engineering ¹ÚÁ¾Àº(KAIST ÀÇ°úÇдëÇпø)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:40~10:00 Metabolic and functional adaptation of T cells in the tumor microenvironment ÀÓ¼±¾Æ(ÀÌÈ¿©ÀÚ´ëÇб³ »ý¸í°úÇаú)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:00~10:20 Application of single cell mega-atlas in drug target and biomarker discovery ¹ÚÁöȯ(GIST »ý¸í°úÇкÎ)
ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:20~10:30 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:30~11:10 Acquired epithelial WNT secretion drives niche independence of developing gastric cancer ±¸º»°æ(IBS)
Åä·Ð 11¿ù 07ÀÏ 207-211È£ 11:10~12:00 Poster Presentation ()
½Ä»ç 11¿ù 07ÀÏ 204-205È£ 12:00~13:00 ÆòÀÇ¿øȸ & ½Ä»ç ¸íâ¼±(Ãæ³²´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:00~13:20 Successful Drug Repositioning for Rare Genetic Disease À̹üÈñ(¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:20~13:40 The role of TET enzymes in Cancer Immunotherapy ¼Çü¼®(¼¿ï´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:40~14:00 Divalent oligonucleotides are bioavailable in the lung and efficiently block SARS-CoV-2 infection ½Å¹Î¿í(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:00~14:20 CLDN18.2-targeting ADC for gastric cancers prepared by AbClick¢â Pro Á¤»óÀü(¼º±Õ°ü´ëÇб³ ¾àÇдëÇÐ)
ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:20~14:30 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:30~15:10 The Interactions between eosinophils and mast cells (THE Allergic Effector Unit)as the ultimate pro-inflammatory cross-talk? Francesca Levi-Schaffer(Hebrew University of Jerusalem, Israel)
ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:10~15:20 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:20~15:50 SREBP-1c regulates hepatic fibrosis via regulating lipocalin-2 expression in NASH Àӽ¼ø(°è¸í´ë ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:50~16:20 Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis Á¤¿µ¹Ì(ºÎ»ê´ëÇб³ ÀÚ¿¬°úÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 16:20~16:50 New roles of G12 family proteins in cellular metabolisms ±èÅÂÇö(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 16:50~17:20 Understanding of human diseases in fuel metabolismperspective using the state-of-the art-metabolomicstechniques ÃÖµ¿¿í(°í·Á´ëÇб³ »ý¸í°øÇкÎ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:00~09:20 The functional analysis of DDX41 in DNA damage response pathway ±èÈ«ÅÂ(UNIST)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:20~09:40 Role of HDAC6 in induced resistance of NSCLCs against radiation therapy ±è¿ì¿µ(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇкÎ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:40~10:00 Mechanisms that limit replication fork stress and genomic instability ±â¿µÈÆ(DGIST)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 10:00~10:20 Bromodomain proteins are protectors against endogenous DNA damage ±èÀçÁø(ÇѸ²´ëÇб³ »ý¸í°úÇаú)
ÈÞ½Ä 11¿ù 07ÀÏ 204-205È£ 10:20~11:10 ÈÞ½Ä ()
½Ä»ç 11¿ù 07ÀÏ 204-205È£ 12:00~13:00 ÆòÀÇ¿øȸ & ½Ä»ç ¸íâ¼±(Ãæ³²´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:00~13:13 Successful Drug Repositioning for Rare Genetic Disease ·ùÁÖÈñ(¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:13~13:26 The role of TET enzymes in Cancer Immunotherapy À±¼Ò¹Ì(¼¿ï´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:26~13:39 Divalent oligonucleotides are bioavailable in the lung and efficiently block SARS-CoV-2 infection ÇÑÁÖÈñ(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:39~13:52 CLDN18.2-targeting ADC for gastric cancers prepared by AbClick¢â Pro ½Å¹Î±Ô(¼º±Õ°ü´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:52~14:05 Optical sensing and control of protein activity for the study of brain diseases ¼ºÁöÇý(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 14:05~14:18 First-in-Human Study of J2H-1702, a Novel 11¥â-hydroxysteroid Dehydrogenase Type 1 Inhibitor ÀÌ»ó¿ø(ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ)
ÈÞ½Ä 11¿ù 07ÀÏ 204-205È£ 14:18~15:20 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 15:20~15:50 SREBP-1c regulates hepatic fibrosis via regulating lipocalin-2 expression in NASH °Á¾¼ø(¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 15:50~16:20 Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis À±¹Ì¼·(°¡Ãµ´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 16:20~16:50 New roles of G12 family proteins in cellular metabolisms ±èÇö¿ì(KAIST »ý¸í°úÇÐ)
±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 16:50~17:20 Understanding of human diseases in fuel metabolismperspective using the state-of-the art-metabolomicstechniques ¹è±Ô¿î(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)